Village Farms International (VFF) Q2 2026: 74% Export Growth Fuels Margin Expansion and Operational Scale
Village Farms International's second quarter showcased robust international export growth and operational efficiencies driving significant margin expansion. The company’s global cannabis platform capitalized on record yields and strategic facility expansions, underpinning strong profitability despite market complexities. Looking ahead, Village Farms is positioned to leverage its EU GMP certification and facility scale to sustain growth and margin leadership.
Summary
- International Export Momentum: Village Farms accelerated global cannabis exports, notably gaining share in Germany and expanding EU GMP-certified product sales.
- Operational Efficiency Gains: Record harvest yields and scale at the Delta British Columbia facilities drove nearly 10 percentage points of gross margin improvement year-over-year.
- Strategic Facility Expansion: The phased Delta II greenhouse expansion is set to add 40 metric tons of annual production capacity by 2027, supporting future growth and cost advantages.
Business Overview
Village Farms International operates as a global cannabis cultivator and distributor, generating revenue primarily from its cannabis segment, which includes medical and recreational cannabis sales across Canada, Europe, and other international markets. The company’s business model leverages large-scale greenhouse cultivation facilities, notably in Delta, British Columbia, and the Netherlands, with a focus on producing EU Good Manufacturing Practice (EU GMP) certified cannabis products that meet stringent pharmaceutical standards. The legacy produce business was divested in 2025, allowing Village Farms to concentrate exclusively on cannabis operations.
Performance Analysis
In Q2 2026, Village Farms reported consolidated net sales of $64 million, marking a 7% year-over-year increase driven by a 74% surge in international medical cannabis exports and a 35% increase in sales from the Netherlands recreational cannabis business. The cannabis segment, representing the majority of revenues, delivered a 5% increase in net sales compared to the prior year. Gross margin for the cannabis segment expanded by 900 basis points to 51%, reflecting a favorable sales mix weighted towards higher-margin EU GMP-certified products, enhanced operating efficiencies, and a lower cost of production at the Delta campus.
Adjusted EBITDA from continuing operations was $15.4 million, representing 24% of sales, a slight decline from last year’s 28.5% due to a one-time $4.3 million vendor settlement recorded in the prior year quarter. Excluding this settlement, adjusted EBITDA increased approximately 20%, underscoring the underlying strength of the business. The company generated positive cash flow from cannabis operations of $8.9 million, despite higher Canadian income tax payments and working capital changes related to extended export sales terms.
- Export-Led Growth: International sales growth outpaced domestic markets, with Germany emerging as a key driver supported by Village Farms’ dominant pharmacy distribution and four of the top ten market strains.
- Margin Expansion Drivers: The shift towards EU GMP-certified products and operational scale at the Delta facility contributed to nearly 10 percentage points of gross margin improvement year-over-year.
- Capital Deployment: With $15 million spent on capital expenditures in the first half of 2026, primarily on Delta II expansion and Netherlands facilities, the company is primed for scalable growth without near-term additional CapEx requirements.
The company’s disciplined cost management and strategic focus on high-value international markets underpin a sustainable profitability trajectory as it prepares to ramp up production capacity in the coming years.
Executive Commentary
"We delivered our fifth consecutive quarter of positive net income and earnings per share since we privatized our legacy produce business last year. Record yields combined with greater operating efficiencies have resulted in lower cost of production and favorable sales mix also helped drive nearly 10 percentage points of year-over-year gross margin expansion."
Michael DeGiglio, Chief Executive Officer
"Adjusted EBITDA from continuing operations for cannabis improves 16% to a record of $15.3 million from $13.1 million in Q2 of last year, resulting in adjusted EBITDA margin of 29%. We believe we are the first and only major Canadian public cannabis LP in the position of paying corporate income taxes, which remains a testament to the strength of our operating capabilities and the sign of a sustainable, long-term, profitable platform."
Steve Ruffini, Chief Financial Officer
Strategic Positioning
1. Leveraging EU GMP Certification for Competitive Advantage
Village Farms’ Delta facilities are the world’s largest EU GMP-certified cannabis production site, enabling the company to meet stringent pharmaceutical standards required by European regulators. This certification is a significant barrier to entry for competitors and positions Village Farms to capture growing demand in regulated international markets, particularly Germany, the UK, and Australia.
2. Phased Expansion of Delta II Facility to Drive Scale and Efficiency
The ongoing conversion of the 1.1 million square foot Delta II greenhouse, completed in phases, will add 40 metric tons of incremental annual production capacity by 2027. This expansion is expected to further reduce costs through economies of scale and enhance flexibility to meet diverse customer demands across global markets.
3. Focused Growth in Convenience Product Categories in Canada
Village Farms has strategically targeted convenience product categories such as vapes and infused pre-rolls, achieving top 10 market share in all major Canadian segments. This organic growth in branded products strengthens in-house capabilities and supports future non-Canadian market expansion.
4. Strategic Positioning in Emerging Recreational Markets
The company’s participation in the Netherlands’ recreational cannabis pilot program, including the operation of the Phase II Chronogen facility, positions Village Farms for a potential tenfold increase in market size if the program expands. Positive feedback from municipalities and coffee shop owners underscores the long-term potential in this market.
5. Balanced Capital Allocation and Financial Discipline
Village Farms maintains a strong cash position of $73 million and a net cash balance of $33 million after debt, enabling continued investment in growth initiatives while returning capital to shareholders through share buybacks and disciplined expenditure. The company’s balanced approach supports sustainable free cash flow generation and shareholder value creation.
Key Considerations
Village Farms’ second quarter performance reflects a mature and scalable cannabis platform with differentiated assets and strategic market positioning.
- International Market Penetration: The company’s growing share in Germany and expanding export footprint underscore its ability to capitalize on regulatory-compliant product demand.
- Operational Efficiency as a Moat: Large-scale greenhouse operations and continuous yield improvements provide a cost advantage difficult for smaller competitors to replicate.
- Regulatory and Market Risks: The evolving regulatory landscape, especially in the U.S. and Europe, requires careful navigation to maintain market access and certification standards.
- Product Mix and Pricing Dynamics: While Canadian domestic pricing shows signs of plateauing, international markets and convenience product categories offer growth and margin expansion opportunities.
- Facility Expansion Execution: Successful ramp-up of Delta II and Netherlands facilities is critical to sustaining growth and meeting increasing demand.
Risks
Village Farms faces risks related to regulatory uncertainties, particularly regarding U.S. market entry and evolving international cannabis laws. Pricing pressures may emerge as supply increases in mature markets, and operational execution risks exist around facility expansions and maintaining EU GMP compliance. Additionally, extended payment terms in export markets could impact working capital and cash flow timing.
Forward Outlook
For Q3 2026, Village Farms anticipates continued growth driven by ramping production from the Delta II expansion and the Netherlands Phase II facility. Management expects adjusted EBITDA margins to remain robust, supported by cost efficiencies and favorable product mix.
- Incremental 15 metric tons of production expected from Delta II expansion in 2026, scaling to 40 metric tons by Q3 2027.
- Continued strong performance in international medical exports, particularly in Germany and emerging European markets.
For full-year 2026, management projects stronger free cash flow generation in the second half, reflecting completed capital expenditures and operational scale benefits. The company maintains a balanced capital allocation approach, prioritizing shareholder returns and strategic investments.
Takeaways
Village Farms International’s Q2 results highlight its strategic execution and operational leverage in the global cannabis industry.
- Export Growth as a Growth Engine: The 74% year-over-year increase in international exports, especially to Germany, validates Village Farms’ EU GMP certification strategy and positions the company as a dominant global supplier.
- Margin Expansion Reflects Operational Scale: Nearly 10 percentage points of gross margin improvement underscore the benefits of large-scale, efficient cultivation and a premium product mix.
- Future Growth Hinges on Facility Expansions: The phased Delta II expansion and Netherlands facility ramp-up are pivotal to sustaining volume growth and margin gains, with minimal near-term capital requirements beyond current projects.
Conclusion
Village Farms International’s second quarter demonstrated a resilient and profitable cannabis platform driven by international market penetration, operational scale, and strategic facility expansions. The company’s focus on EU GMP certification and convenience product categories positions it well for sustained growth and margin leadership amid evolving regulatory landscapes.
Industry Read-Through
Village Farms’ emphasis on EU GMP certification and large-scale greenhouse operations signals a growing industry trend towards pharmaceutical-grade cannabis production to meet stringent regulatory requirements in Europe and other international markets. Their success in expanding export volumes and market share in Germany reflects the importance of compliance and scale in global cannabis supply chains. Other industry participants should note the challenges and capital intensity associated with achieving and maintaining EU GMP certification, as well as the strategic value of focusing on convenience product categories to drive branded growth in mature markets. The company’s balanced approach to capital allocation and disciplined cost management may serve as a model for sustainable profitability in a competitive and evolving sector.